These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34111282)

  • 1. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.
    Porter RJ; Arends MJ; Churchhouse AMD; Din S
    J Crohns Colitis; 2021 Dec; 15(12):2131-2141. PubMed ID: 34111282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
    Frigerio S; Lartey DA; D'Haens GR; Grootjans J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease.
    Chen T; Shi N; Afzali A
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31163684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.
    Bragg MA; Breaux WA; M'Koma AE
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37476546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution of colorectal cancer in IBD.
    Choi CR; Bakir IA; Hart AL; Graham TA
    Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):218-229. PubMed ID: 28174420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
    Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
    Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer.
    Shi R; Wang S; Jiang Y; Zhong G; Li M; Sun Y
    Front Endocrinol (Lausanne); 2024; 15():1348216. PubMed ID: 38516408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).
    Wang Z; Chang Y; Sun H; Li Y; Tang T
    Oncol Lett; 2024 Jun; 27(6):257. PubMed ID: 38646499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Colorectal Cancer.
    Long AG; Lundsmith ET; Hamilton KE
    Curr Colorectal Cancer Rep; 2017 Aug; 13(4):341-351. PubMed ID: 29129972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Pip pip to PIP's (post-inflammatory polyps) as a neoplasia risk factor in IBD?
    Velayos FS
    Aliment Pharmacol Ther; 2023 Aug; 58(3):361-362. PubMed ID: 37452585
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular mechanisms in colitis-associated colorectal cancer.
    Zhou RW; Harpaz N; Itzkowitz SH; Parsons RE
    Oncogenesis; 2023 Oct; 12(1):48. PubMed ID: 37884500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease.
    Zeng Z; Mukherjee A; Zhang H
    Front Genet; 2019; 10():1017. PubMed ID: 31737035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solving the Puzzle: Molecular Research in Inflammatory Bowel Diseases.
    Krug SM
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Impact of Obesity on Disease-specific Outcomes in a Population-based Cohort of Patients with Ulcerative Colitis.
    Johnson AM; Harmsen WS; Aniwan S; Tremaine WJ; Abu Dayyeh BK; Loftus EV
    J Crohns Colitis; 2021 Nov; 15(11):1816-1823. PubMed ID: 34117877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: Colorectal cancer endoscopic surveillance in IBD.
    Din S; Gaya DR; Arnott IDR
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):526-527. PubMed ID: 34119037
    [No Abstract]   [Full Text] [Related]  

  • 17. Rectal Cancer Incidence is Low Following Rectal Diversion or Subtotal Colectomy for IBD: Results of a Population-based Study.
    Brar MS; de Buck van Overstraeten A; Baxter NN
    J Crohns Colitis; 2021 Nov; 15(11):1787-1798. PubMed ID: 34165532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.
    Baumgartner M; Lang M; Holley H; Crepaz D; Hausmann B; Pjevac P; Moser D; Haller F; Hof F; Beer A; Orgler E; Frick A; Khare V; Evstatiev R; Strohmaier S; Primas C; Dolak W; Köcher T; Klavins K; Rath T; Neurath MF; Berry D; Makristathis A; Muttenthaler M; Gasche C
    Gastroenterology; 2021 Oct; 161(4):1245-1256.e20. PubMed ID: 34146566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
    Allegretti JR; Canakis A; McClure E; Marcus J; Norton BA; Hamilton MJ; Winter RW; De Silva PS; Friedman S; Korzenik JR
    Inflamm Bowel Dis; 2021 Nov; 27(12):2031-2033. PubMed ID: 34142700
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint.
    Lee J; Lemons N; Lorenze A; Chowdhary TS; Zinn Z; Gayam S
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3278-3285. PubMed ID: 34139789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.